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?????????? ?????? ????? ? ?????????? ? ??? ????????????????? ???????. ????? ???????????? ?????
?????????? ? ??????????? ?????????????????? ??????? ??????? ?????????? ? ??????????? ?? ?????
???????? ????????????. 131 ?????????? ? I ????????? ???? ?????????????? ??? ??????????? ????? ????????
????????????. ?????? ???????? ????????? ??????? ?????????? ?????? ????? ???????? ?????????????? ????-
????? ?? ??????????? ???????????? ????? ??????????? (??????? ???????????? 455 G?A ? ???? ???????-
???? ? ? 4G/5G ? ???? ?????????? ?????????? ???????????? - 1 ????), ?????? ??????? ? ?2 ????????????? 1, 
???????????? ?-??????, ???????? ???????????? ?????????????. ?????????? ?????? ???????????????
???????? ????? ???????? ???????????? ???????? ???????? ????????????????? ???????, ??????? ???????:
??????????????? ???????, ????????? ?????? ???????????? ? ???????????????????. ??????????? ????-
???????????????? ????????? ??????????????? ? ???????????? ????????????, ??????????????? ? ??????-
??????. ????????????? ??????? ????????? ????????????? ?????????? ??????????? ?????, ?????? ???????,
??????? ???????????? ???????? ???????????. ???????? ????????????? ??????? ? ??????????? ??????????
?????????????? ????????????????? ?????????, ??? ????????? ?????????? ????????????? ???????????,
???????? ??????????? ????????? ? ????????????? ???????? ??????????????? ????? ????????????. ??-
????????? ????????????????? ??????? ??????? ???????? ??????? ???????????? ? 6,5 ??? (? <0,05), ??????????
??????????? ????? ? 3 ???? (? <0,05), ??????????????? ????? ? 6,5 ???? (? <0,05), ???????? ???????? ????? ?
9,8 ???? (? = 0,003), ?????????? ????? ???? ????????????? ? 1,24 ???? (? = 0,02). 
Abstract. Clinical management of pregnant women with the risk of pre-eclampsia developing. Loskutova T.O.
Hypertensive disorders in pregnancy remain important problem of modern obstetrics, their frequency being 2-8% with 
no tendency of decreasing. To identify pregnant women with high risk and to conduct preventive treatment is very 
important for the practitioner. The aim of the study was to develop and justify differential management of pregnants 
depending on the risk of preeclampsia. 131 pregnant women in I trimester were tested to determine the risk of 
hypertensive disorders. Prediction model allows to identify pregnant women with risk of hypertensive disorders 
according to the results of testing thrombophilia genes (presence of 455G ? A polymorphism in the gene for fibrinogen 
? and 4G/5G in gene of plasminogen activator inhibitor - type 1), the level of antibodies to ?2 glycoprotein-1, the level 
of D-dimer and the value of atherogenicity coefficient. Pregnant women with high risk of hypertensive disorders, 
received prophylactic treatment complex. This complex included antiplatelet therapy, correction of hyperhomo-
cysteinemia and hypercholesterolemia levels. Etio-pathogenic concept of prediction and prevention of pre-eclampsia 
associated with thrombophilia was proposed. The proposed scheme of preventive treatment allowed to normalize blood 
clotting parameters, lipid metabolism, to reduce the number of thrombophilia markers. The necessity of early and long-
term administration of prophylactic complex was proved. This management prevents endothelial damage and deve-
lopment of pathological range of pre-eclampsia. The results of prophylactic treatment were the reduction of 
preeclampsia cases by 6,5 times (p < 0.05), number of complicated deliveries by 3 times (p <0.05), number of preterm 
birth by 6,57 times (p <0.05), cases of growth retardation by 9,8 times (p = 0.003), increase of newborns’ weight by 
1,24 times (p = 0.02). 
???????? ?????? ??????? ??????? ????????
????? ?????? ???????? ???????????? (??) ?????-
??? ???????? ??????? ?????????? ?? ????????
???????, ?? ????????? ??????? ???????? ?? (2-
8 %), ? ????? ???????? ?????????? ??? ?????? ?
??????, ?? ??????????????? ??? ?????. ???
??????-???????? ?????????? ???????? ? ?????-
???? ???????? ????? ???????? ?????? ????????
?? ?? ??????? ??????? ???????. ?? ????????, ???
?????? ?????????? ????? ???????? ?? ? ????????
?? ????? ? ??????????, ???????? ??????????? ??
??????????? ????? ???????????. ? ???????????
Woodham ?.?. et al. (2011) [8] ???? ????????, ??
????? ? ????????? ????????? ? ??????????????
?????????? ?????????? ??????????? ??????????
?????????? ??? ?????????? ???? ??????????? ??
?????????? ????????????? ????????? ??? ??-
??????? ???????????. ???????? ????? ?????? ??
?????????? ?? ???????? ????? ??? ?????????
???????????, ??????????, ???????? ???????,
???????????????? ???????????? [9,10], ????? ???
????? ?? ???????????? ???????? ????? ????????
?????? ?? ??????????? ???????? ??.
?? ???????????? ??? ????? ????? ??????-
????? ???????? ???? ???????????? ????????????
? ???????? ?? ?????????? ?? ???????? ???????
???????????. ?????? ? ??????? ??? ???????
? 676 ??? 31.12.2004 ????, ???????????? ?? ??-
???????? ??????????? ???????? ????? ??????
????????????????? ??????? 60-100 ??/????, ????-
????? ? 20 ????? ??????????, ?????????? ???????
2 ?/???? ? 16 ?????? ?????????? ?? ????????? ??
??????? ?????????? ???????? ????????? ?? ??-
????? ??????? ??????????????? ?????? ??????
[3]. ????? ???????? ???????? ????? ???? ????????
??? ???????????? ??????????? ??????? ???
???????? ? ????? ???????????? ????????????,
????????? ? ?????? ???????? ??????????, ?? ??
????? ?????????? ???????? [7]. ???? ????, ???-
???????? ????????? ? ???????? ????? ????????





????? ??????????? ????? ???????? ?? ??????-
??????? ???????????????? ??????? ??????? ?????-
??? ??????? ??? ????? ?????? ???????? ??.
????????? ?? ?????? ??????????
??? ???????? ???????????????? ???????
??????? ???? ????????? 131 ??????? ? ? ?????????
??????????. ??????? ???? ???????????? ?? ???????-
??????? ???? ???????? ????????????? ?? ???
?’???????? ????? ?????? ???????? ?? [1].  
?? ???????????? ?????????? ???? ??????????
????? ???????????:
- ??????? ?? ?????????? ???????????? ????????
???????????? ????? ??? 0,683 ?????????? ?????
???????? ?????? (??) ???????? ?? – 84 ???????.
?? ??????? ?????????????? ?????????? ?? ??????
????????? ?????????? ?? ??????? ??? ???????;
- ??????? ?? ?????????? ???????????? ????????
?? ?????? ??? 0,683 ?????? ????? ????????
?????? (??) ???????? ?? – 47 ????????. ????? ??
???? ???????? ?? 2 ????????: ??????? (?) – 23 
???????, ??? ?????????? ?????????????? ????
???????? ???????????????? ???????????? ??, ??
?????????? (?) – 24 ???????, ??? ?????????? ???-
???????? ???????? ???????????? ?????? ? ???-
??? ????????? ?????????? ??? ???????.
???????????????? ???????? ????????????
???????: ???????????????? ??????? 75 ??/????
(????????????) ? 14-38 ????? ??????????; ???????
??????? 0,8 ??/???? ??? 4 ??/???? ??? ?????????-
??????????? ??/??? ???????????? ??????? ????
MTHFR 677TT ?? ???????? ????? ?: ??????????
(??????? ?1) – 25 ??/????, ?????????? (???????
?2) – 2,5 ??/????, ??????????? ???????????
(??????? ?6) – 40 ??/????, ?????????????? (??-
????? ?12) – 0,25 ??/???? (??????????) ????????
????? ?????????? ?? 1 ?????? ????? ???????; ??????-
???????? ????? ???????: ???????? ???? ??????-
??????????? ??????? 300 ??/????, ???????? ????
????????????????? ??????? – 200 ??/????, ?????-
????????? – 2 ??/???? (?????? ?????? ????? 3) 
???????? ????? ??????????.
? ???? ???????? ??? ?????????? ????? ????? ?
????? ?????????? ?????? ?????????????, ?????
??????? ?????????, ?????? ???????, ????? ????-
????????????? ??????? (???). ???????????,
????? ??????????, ????????? ?? 8-9 ?? 24-26 ??-
???? ??????????.
??????????? ?????????? ????????????? ???-
?????? ?????? ???????????????? ????????????
?????????? ???????, ? ????????? ????????? ??-
????? ????????????? ? 3% ?????????? ????.
???????????????? ???????? ????????? «SNP-
???????» ??????????? ??? «?????» (?????) ???
?????????? ????????????? ? ?????? ??????: 675
5G? 4G ? ???? ?????????? ?????????? ??????????-
?? -1, ??????????? 455 G ? A ? ???? ???????????
?, ??????????? 677 C ? T ? ???? ???????-
???????????????????????? (MTHFR). 
??????????? ?????????????? ??????????
??????????? ? ?????????? ??????? ???????????
????????? ?? ??????????? ?? 2110 «?????»
(?????????). ??? ??????????? ???????????????-
???? ????????? ????? ????????? ???????? ??????-
????????? ????????? (????), ???????????????
?????? ?? ????????? ????????????? «????-
????» ????? ?????????? ???????? (?????), ? ?????
?????? ?-?????? ? ?????? ????? ??????????-
??????????? ???????? ?? ????????? ??????-
????? «Tina-quant ? D-Dimer» (Roche Diagnostics, 
???) ?? ??????? Roche/Hitachi ?obas c 6000. 
?????????? ???????????? ?????????? ???????-
???? (??), ??????????? ????????????? ???????
????????? (?? ????), ??????????? ???????-
?????? ??????? ????????? (?? ????), ??????-
??????? (??) ? ?????? ????? ??????????? ?? ????-
????????? ??????????? «Biochemistry Analyzer 
88», ? ????????????? ????????? «???-??-????»
(Lachema-Pliva, ?????? ??????????). ??????????
????????????? (??) ????????????? ?? ????????:
?? = (??? - ??????) / ??????.
?????????? ???????? ??????? ?????? Ig M ? Ig 
G ?? ?2 ????????????? 1 ????????? ??????? ??-
??????? ????????????? ???????????????? ???-
???? (ELISA) ? ????????? ????? ?? ?????????
????????? ??????????? «Orgentec Diagnostica 
GmbH» (?????????).
???????????? ?????? ?????????? ?? ??????-
??? ??????????? ???????????? Microsoft Excel 
2010 ? GrafPad Prism 5 ??? Windows. ??? ?????-
????? ??????? ?????????? ??????????????? ???-
????? ?2. ??? ????????? ??????????? ??????? ??-
?????? (????????? ??????????, ???????????? ? ??-
????????? ??????????) ???? ??????????? ??????
1, 2 ? 3 ??????????. ??? ?????????? ?????????? ??-
????? ??????????????? ???????? ???????? t. ??
???????? ????? ?????? ????????????? ?<0,05 [5]. 
?????????? ?? ?? ???????????
???????? ???????????? ???????? ?? ?? ???-
???????? ???? ???????? ? ???????? ????? ??
????????? 0,12±0,018, ?? ??????? ????? ?? ??-
??????? ????? ?? (0,79±0,04, ???<0,001): ? ?????
? (0,75±0,07, ???<0,001), ? ????? ? (0,82±0,07, 
???<0,001). ??? ??? ????????????? ? 3 (14,3%) 
????????? ????? ? ?????????? ??????????? ?
???????? 10-14 ??????, ? ????? ? ???????????
?????????? ?? ???????????, ? ????? ?? ?? ???-
?????? ? 3 (3,7%) ?????????.
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???????? ???????-????????????? ????????
?????? ? ???????? ?? ??????????? ??? ????? ??
(?<0,05): ?????? ???? ???? ??? ?????? ? 1,06 ????
(24,46±0,75 ????? 22,97±0,35), ???????? ??????-
??????? ? 4,17 ???? ??????? (14,89% ?????
3,57%), ?????????? ??????????? ?????????? ?
2,46 ???? ??????? (46,81% ????? 19,05%). ?????
????????????????? ??????????? ? ????? ?? (?
4,17 ????) ??????????? ????????????? ?????-
???????????? ???????? ?? ????????????? ?????
?? (? 2,98 ????) ????????? ??????? ?????? ???-
????? (???<0,05).
???????? ????????? ?????? ????????????? ?
????????????? ?????? ???????? ?????????? ???-
???????? ??? ?????? ?? ? ??????? ?? (????. 2), ?
????: ????? ????????? ?????????? ?????????
???? PAI-1 5G/5G ? ????? ?? ?? ? ????? ?
(?<0,05), ?????? ????????? ????????? ?????????
???? PAI-1 4G/4G ? ??? ?? ?????? (?<0,05);
????? ????????? ?????????? ????????? ????
??????????? ? 455 GG ? ????? ?? (?<0,05). 
??????????? ???????????? ? ????????? ??????
????????????? ??? ??????? ? ? ? ?? ????????
(?>0,05).
? ? ? ? ? ? ?  2  
???????? ?????? ????????????? ? ???????? ???? ??????????? n (P, %) 
????? ??????????? ???????
PAI-1 5G/4G 
 5G/5G 5G/4G 4G/4G 
??, n=47 9 (19,5) ?? 33 (46,81) 16 (34,04) ??
?, n=23 4 (17,39) 12 (52,17) 7 (30,43) 
?, n=24 3 (12,5) ?? 11 (45,83) 10 (41,67) ??
??, n=84 32 (38,1) 41 (48,81) 11 (13,1) 
?????????? ? 455 G?A
 GG GA AA 
??, n=47 21 (44,68) ?? 16 (34,04) 10 (21,28) 
?, n=23 10 (43,48) 8 (34,78) 5 (21,74) 
?, n=24 11 (45,83) 8 (33,33) 5 (20,83) 
??, n=84 55 (65,48) 22 (26,91) 7  (8,33) 
MTHFR 677 C?T
 CC CT TT 
??, n=47 25 (53,19) 18 (38,3) 4 (8,51) 
?, n=23 11 (47,83) 10 (43,48) 2 (8,7) 
?, n=24 14 (58,33) 8 (33,33) 2 (8,33) 
??, n=84 57 (67,86) 23 (27,38) 4 (4,76) 
? ? ? ? ? ? ? ? . ?? - ??????? ?????????? ??????????? ????????? ? ?????? ?? (? < 0,05). 
???????????? ?????? ?????? ??? ? ? ?????????
??? ????? ??????? ???? ??????????? ? ?????? ?? ??-
??????? ? ?????? ?? (4,21±0,43 ??/??, ?<0,001): 
????????? ??????? Ig M/G ?? ?2 ??-1 ? ? ?????
(6,2±0,79??/??) ???? ?????? – ? 1,47 ????, ?
????? ? (6,76±0,89 ??/??) – ? 1,61 ????. ????-
????? ??????? ?? ?2 ??1 ? ?????? ???????? ??-
???????? ???? ????????? ?? ????????? ? ????
??????, ??? ????????? ?????????? ? 1,58 ???? ?
????? ? (4,03±0,58 ??/??, ??1=0,04) ?? ?? ????
???????????? ??? ????? ?? (3,9±0,25 ??/??,
??2>0,05). ? ????? ? ????????? ??????? ????????-
???? ???????? ????? ?? ? 1,39 ????
(5,43±1,04 ??/??, ???2=0,04). 
???????????? ???????????? ? ? ????? ??????-
???? ? 1,5 ???? (10,61±1,49 ??????/?, ?=0,03), ?
????? ? – ? 1,6 ???? (11,36±0,9 ??????/?, ?<0,001) 
?????????? ? ??????????? ????? ??
???????? ????????
??????? ???????????66
(7,08±0,72 ??????/?). ? ?????? ???????? ?????-
????? ?????? ???????????? ? ? ????? ????????? ?
1,4 ???? (7,58±2,33 ??????/?) ?? ?? ???????????
??? ????? ?? – 7,72±0,63 ??????/?. ? ????? ?
?????? ???????????? ?????????? ? 1,01 ????
(11,46±0,6 ??????/?) ?? ????????? ???????????
???????? ????? ? (?=0,03) ?? ????? ??
(?=0,0019). 
?????????? ????????????? ? ? ????????? ???
???????????? ??????? ?? ??????????? (?>0,05) ??
???????? ? ????? ?? 3,49±0,12, ? ?????? ? ?? ?
3,59±0,16. ? ?? ???????? ????? ?? ??????????
??????????? ??????? ??????????? ?? ??? ?????-
????? ??????????????? ???????, ?? ?? ????????
?? ?????????? ?? (3,38±0,13, ???1>0,05). ? ?????
? ??????????? ?????????? ?? ?? ??????? ? ??????
?? ?? ???? (3,79±0,17, ??1, ??2 >0,05). ? ????? ?,
?? ?? ?????????? ??????????? ?????????, ?????-
????? ??????????? ??????? ?? ?????????? ?????-
????? ??????????????? ???? ???????? ??
?????????? ??????????? ????????????? (4,2±0,26, 
??1,??2<0,05). 
?????? ????? ???????? ??????????? ?????????
???????? ??????????? ????????? ?-??????, ????
??? ??????? ?????????????. ???????????? ?-??-
???? ?????????? ? 3,5 ???? ? ????? ?
(1,4±0,4 ???/??), ? 2,02 ???? ? ????? ?
(0,89±0,1 ???/??) (?<0,001) ?????????? ?? ??????-
?? ????? ?? (0,44±0,02 ???/??). ????? ???????
?????? ?-?????? ? ????? ? ???'????? ? ???, ?? ???
??????? ???? ????? ??? ?? ??????? ?????????? ????
?????? ?????????, ?? ????????? 3,84, 5,15, 
7,25 ???/??. ???? ????, ???????? ????? ??? ???
??????? ???? ??????????? ??????? ???????????
20210 ??, ???? – ??????????? ????????? ????-
??? ?? ????????????? ??????? FVL, ?? ? ?????
???????????? ???????????????? ?????????? ??
?????????? ?? ???????????? American ?ollege of 
?hest ?hysicians (2012) [6] ???? ????????????
???????? ???????????????? ?????????? ?? ??-
???????? ?????????? ? ???????? ? ????????????
???? ????????? ?????????? ??? – ??????????
??????? 0,3 ?? ????????? ???????? ?????????? ??
1 ??????? ????? ???????. ????????? ???? ????
??????? ? 2,18 ???? ? ? ????? (9,7±1,1 ??/%) ?? ?
1,96 ???? ? ????? ? (8,7±0,9 ??/%) (?<0,001), ??-
???????? ? ?????? ?? (4,45±0,3 ??/%). ??? ???-
???? ? ? ? ???????? ???????????? ?? ????????
(?>0,05). ? ?????? ???????? ?????????? ??????
???? ? ? ????? ???? ????????? – ? 1,14 ????
(8,5±0,6 ??/%, ??1>0,05, ???2<0,05), ????? ???
??????? ? 1,46 ????, ??? ? ????? ??
(5,8±0,3 ??/%, ???1<0,05). ? ????? ?????????? ??-
???? ???? ????????? ????????? ???????
(12,25±1,3 ??/%, ??1 <0,05) ? ??? ????????? ??????
? 2,11 ????, ??? ? ????? ?? (???2<0,05), ?? ?
1,43 ????, ??? ? ? ????? (??2<0,05).
????????? ??????????? ??? ??????? ?? ?????-
?? ?????????? ?? ???????????? ?? ?????????
(213,3±8,6)*109/?, (208,8±8,1)*109/? ??
(222,4±3,93)*109/? ? ?????? ?, ? ?? ?? ?????-
????? (?>0,05). ??????? ????????? ??????????? ???
??????? ? 1,28 ?? ? 1,34 ???? (?<0,05) ? ?????? ?
(68,76±5,5 %) ?? ? (72,35±5,6 %) ??????????,
????????? ? ?????? ?? (53,86±3,6%).  
???????? ?????????? ???????-???????????-
??? ????? ????????? ??? ?????????? ??????????
????????, ?? ????????? ???????? ?????????
??????????? ????????? ? ????? ?: ? 1,16 ????, ???-
????? ?? ?????? ? ????????? (179,5±11,8)*109/?,
(??1<0,047), ? ????? ?? ((203,5±6,4)*109/?,
?<0,05) ?? ????????? ?????????? ? 1,09 ????. ????-
????? ??????????? ? ????? ? (191,0±7,3)*109/?,
(??1,??2>0,05) ??????? ?? ?????????.
? ???????? ?????????? ?????????? ??????????
??????? ????????? ???????????: ? ? ?????
(81,05±9,3)%, (??1>0,05) – ? 1,12 ????, ? ????? ??
(59,46±4,6)%, (???1>0,05) – ? 1,1 ???? ??????????,
???? ????, ? ????? ? ??? ??? ????????? ?????,
??? ? ????? ?? (?<0,05). ? ????? ? ?????????
???????? ???????? ??????? ????????? ??????-
????? (63,71±8,9) %, (??1>0,05), ?? ??????? ??
???????????? ??? ????? ??2 (?>0,05).
?????????? ?????????????? ?????????????-
??? ????? ???????????? ? ???????? ???? ????-
??????? ????? ?? ??????? ??????????, ??????? ??
???? ??????????????. ? ?????, ?? ??????????
?????????????? ????????, ???????? ????????????
??????????? ??????? ?????????? ????????? ?????,
??? ? ????? ? (??=0,02) ?? ?? ??????????? ???
????? ?? (?>0,05) (????. 3). 
??????????? ???????? ???????????? ???????
????????? ?? ???????? ?? ????? ?????? ?????-
?????? ???????, ??????? ????-???????? ?????-
????????, ???????? ???????????? ??????? ??
?????????????? ?????????? ??? ????? ?????
???????????? ????? ??????????. ? ????? ? ??-
?????? ????? ??????? ??? ????????? ??????
(35,48±1,1 ?????), ??? ? ????? ? (38,0±0,5 ?????,
?=0,04) ?? ? ????? ?? (38,3±0,4 ?????, ?=0,003). 
??????? ???? ?????????????? ? ????? ?
(2548±199 ?) ???? ? 1,24 ???? ?????, ??? ? ?????
? (3150±139 ?, ?=0,02), ? 1,33 ???? ?????, ??? ?
????? ?? (3380±60,9 ?, ?<0,0001).
??????????? ??????? ? ? ????? (17,4%) ???? ?
3,0 ???? ?????, ??? ? ? (52,4%, ?<0,05). ??????-
??????? ? ? ????? ????????????? ? 7,66 (4,35% 
????? 33,33%) ???? ?????, ??? – ? 9,8 ????
(8,7% ????? 42,9%, ?<0,05), ??? ? ?????????-
????? ????? ?.
6715/ ??? XX / 1
? ? ? ? ? ? ?  3
??????? ???????????? ? ?????? ?????????????, n (P,%) 
????? ?? ??????? ??????? ?? ?????????? ??????? ???????
? (n=23) 1 (4,35) 1 (4,35)? 2 (8,7)?
? (n=21) 3 (14,3) 6 (28,6)??,? 12 (57,1)??,?
?P (n=81) 2 (2,47) 0 (0,0)? 2 (2,47)?
? ? ? ? ? ? ? ? . ?, ?, ?? - ??????? ?????????? ??????????? ????????? ? ???????????? ??????? ?, ? ?? ?? (?<0,05).  
?????? ?? ?????? ????? ?? 1 ??????? ? ?
????? ???? ??????? ? 1,16 ????, ?? 5 ??????? – ?
1,13 ????, ??? ? ????? ? (?<0,05). ? ????? ?
?????? ???? ????????? ?????, ??? ? ????? ??
(?<0,05) ?? 1 ??????? – ? 1,22 ???? (?<0,001), ??
5 ??????? – ? 1,17 ???? (?<0,001).
????? ?????, ????????? ??????????? ?????-
??? ?????????? ????????????????? ?????????
????????????? ? ???????????? ????????????
(???.).
????-????????????? ????????? ?????????????
?? ???????????? ????????????, ???????????? ? ????????????
????????? ??????????:
?????????? (20210 G?A),  
?????? V Leiden (1691 G?A),
???-1 (5G/4G), ANG ?? (235 M?T), 
FGB (455 G?A) 
?????????? ?????







MTHFR (677 ??T), 
???????????
???????????
?????????? ?? ????????? ????????????? ?? ?? ?????????? ?????? ???????? ??





? ???????????????? ??????? 75 ??/???? ? 14-
38 ?????;?
? ??????? ??????? 0,8 ??/???? ??? 4 ??/???? + 
???????? ????? ? (??? ???????????????????? ??
??????? MTHFR 677 ?T) – ???????? ??????????;
? ???? ???????? ????? ??????????: ?????????
????? ???????????????? ??????? 300 ??/????,
????????? ?????????????????????? ??????? – 200 






???????????? ???????? ???????????, ?????
????????????.
???????? ???????? ????????????: ???????????
????? ??, ????????? ????????? ??????????????
???????-????????? ?????????, ???, ???;
??????????? ???, ???????? ?????, ???,
?????, ?????? ? ?????.
?????????????? ?? ???????????: ???????? ??,
??????????? ? ???? ?????? ??? ?????
??????? ??????:
????????, ???????????? ???????
????????? ??????????? ???????: ??; ?????, ???, ???, ?????????? ??????, ?? ???????? ??
???????? ????????
??????? ???????????68
????, ???????????? ?? ????? ??????????-???-
??????????? ??????? ???????? ??? ?????????,
???????????? ??????? ?? ?????? ????????, ? ??-
??? ??????? ?? ?????? ???????????????????
??????????, ??????????????? ? ??????????? ???-
???? ?? ?????? ?????????????? ??????? ??
???????? ???????? ????? ??????????. ?????????
??????????? ??????????????? ????????? ???????
?? ????? ????? ???????????, ??????? ???????????
? ???????????, ?? ??? ????? ??????????? ???-
?????????? ?????????? ???????? ?? ????????
??????????? ?????????, ????????? ??????-
??????? ????????? ? ???????? ??????? ????
???????????? ????????, ????????? ??.
????????
1. ??????? ????????????? ?? ????????? ??-
????? ????????:
a) ??? ?????? ???????? ?? ????? ?????????
????????? ?????????? ??? ?????????? ?????
?????? ???????? ????????????;
b) ? ???????? ????? ???????? ?????? ????????
???????????? ????????? ????????? ?????????
??????????? ?????????? ??????? ?????????,
???????? ???????????, ????? ????????????,
?????????? ???????????;
c) ???????? ????? ?????? ???????? ?????-
???????? ????????? ??? ???????? ?????????
????????, ???????? ????? ????????????? ?????,
??????????? ?? ?????????????? ?? ????????????.
2. ??????????? ???????? ????????????? ? ???-
????????? ????????????, ???? ??????????? ??
?????????? ????? ?????? ???????? ????????????,
??????????? ????????????? ?? ????????????????
????? ??????????????? ????????? ???????? ??-
??????? ??????? ??????????, ???????? ???????
??????????? ?? ????????????? ??????????.
?????? ??????????
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